This is a standard shelf registration with no immediate offering. Monitor for future prospectus supplements that would specify actual offering size, terms and use of proceeds. The strong earnings report and $2.5B buyback authorization suggest any future issuance would likely be opportunistic rather than distress-driven.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $167.54entry
- T+1 · 6d ago −0.29%α −1.61% · $167.06
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Emerson filed an automatic shelf registration statement (S-3ASR) with no specified offering size, registering an indeterminate amount of debt securities, preferred stock, common stock, warrants, share purchase contracts and share purchase units. The filing is a routine shelf registration by a well-known seasoned issuer, filed five days after reporting strong Q4 FY2026 results with adjusted EPS of $1.86 (above $1.85 consensus) and initiating FY2027 guidance of $7.25 adjusted EPS alongside a $2.5B buyback plan and 7% dividend increase. No immediate dilution or offering is announced; the shelf provides financing flexibility.
Key Facts
- S-3ASR filed on November 9, 2026 as an automatic shelf registration by a well-known seasoned issuer
- No limit on aggregate amount of securities that may be sold under the registration statement
- Securities registered include debt securities, preferred stock, common stock, warrants, share purchase contracts and share purchase units
- Registration fee deferred under Rules 456(b) and 457(r); no fee paid at filing
- Filed 5 days after Q4 FY2026 earnings: adjusted EPS $1.86 vs $1.85 consensus, revenue $5.201B vs $5.12B consensus
- Company initiated FY2027 adjusted EPS guidance of $7.25, a $2.5B share repurchase plan and a 7% dividend increase
- Proceeds from any future offerings would be used for general corporate purposes including working capital, capital expenditures, acquisitions and debt repayment
- Common stock listed on NYSE and NYSE Texas under symbol EMR
Financial Impact
No offering size specified; registration covers an indeterminate amount of securities with fees deferred on a pay-as-you-go basis
Risk Factors
- Future offerings under this shelf could result in dilution for existing shareholders or increased leverage
- No specific offering terms disclosed; potential for debt or equity issuance at management's discretion
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3ASR Filing (Primary) | 0001140361-26-042816 |
| Document: ny20084788x1_ex1-1.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex25.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex5.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex107.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex4-3.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex24.htm | 0001140361-26-042816 |
| Document: ny20084788x1_ex23-2.htm | 0001140361-26-042816 |
| Document: 0001140361-26-042816-index-headers.html | 0001140361-26-042816 |
Track record
11 reports on EMR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $160.65 Now $160.65 −0.00% settles Nov 24
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $167.42 Now $160.65 −4.04% settles Nov 23
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $166.38 Now $160.65 −3.44% settles Nov 20
- Nov 12, 20264d ago 424B5 Neutral 3/10 Entry $166.38 Now $160.65 −3.44% settles Nov 20
- Nov 10, 20266d ago 424B5 Neutral 2/10 Entry $167.54 Now $160.65 −4.11% settles Nov 17
- Nov 9, 20267d ago S-3ASR Neutral 2/10 Viewing Entry $167.54 Now $160.65 −4.11% settles Nov 17
- Nov 4, 202612d ago Press Release Neutral 5/10 No price data
- Nov 4, 202612d ago 8-K Bullish 5/10 Entry $170.44 to $167.06 Now $160.65 −5.74% ▼ −1.98% −1.07% vs SPY
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $161.59 to $164.94 Now $160.65 −0.58% ▲ +2.07% +2.63% vs SPY
- Oct 13, 20264w ago 8-K Neutral 2/10 Entry $163.50 to $160.46 Now $160.65 −1.74% ▼ −1.86% −0.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers